Thomas Metcalfe works in Roche’s Personalised Healthcare (PHC) global ecosystems team which is part of the Roche Pharma PHC. His work focuses on healthcare system partnerships related to PHC, Value Based Healthcare and public private partnerships. He represents Roche within the European Federation of Pharma Industry Associations (EFPIA) Innovation Committee and is the Roche lead in the IMI Health Outcomes Observatories (H2O) project. Prior to this Tom was the Data Policy Lead within Roche Pharma PHC until March 2019. Between March 2015 and March 2018 he was a Strategic Innovation Leader in Roche Pharma Global Product Development with a focus on Digital Health, Innovative Development Pathways and the use of comprehensive genomics profiling technologies in the development of cancer medicines. He joined Roche from Oncotest GmbH, a preclinical CRO focused on oncology models, where he was Managing Director.
Before this Tom spent 7 years working for Roche Pharma as the Global Head of the Biomarker Program (2004-7) and Head of the PHC Portfolio (2007-10). He also spent 10 years working for Roche Diagnostics in a variety of leadership roles in marketing and business development.
Tom studied Biochemistry at King’s College, London University and has an MBA from the Open University, UK.